Molluscum contagiosum virus topoisomerase: Purification, activities, and response to inhibitors

Journal of Virology

Volumn 72, Issue 4, 1998, Pages 3401-3406

  Hwang, Young ^a   Wang, Beibei ^a   Bushman, Frederic D ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR;

ANTIVIRAL ACTIVITY; ARTICLE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PURIFICATION; IMMUNE DEFICIENCY; MOLLUSCUM CONTAGIOSUM; NUCLEOTIDE SEQUENCE; PLASMID; POXVIRUS; PRIORITY JOURNAL; PROTEIN PURIFICATION; VACCINIA VIRUS;

MOLLUSCUM CONTAGIOSUM VIRUS;

EID: 0031925050     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.4.3401-3406.1998     Document Type: Article

References (31)

1. Bushman, F. D., and R. Craigie. 1991. Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. Proc. Natl. Acad. Sci. USA 88:1339-1343.
2. Cheng, C., L. K. Wang, J. Sekiguchi, and S. Shuman. 1997. Mutational analysis of 39 residues of vaccinia DNA topoisomerase identifies Lys-220, Arg-223, and Asn-228 as important for covalent catalysis. J. Biol. Chem. 272:8263-8269.
3. Fields, B. N., and D. M. Kinpe. 1990. Virology. Raven Press, New York, N.Y.
4. Gottlieb, S. L., and P. L. Myskowski. 1994. Molluscum contagiosum. Int. J. Dermatol. 33:453-461
5. Gupta, M., A. Fujimori, and Y. Pommier. 1995. Eukaryotic DNA topoisomerases I. Biochim. Biophys. Acta 1262:1-14.
6. Klemperer, N., D. J. Lyttle, D. Tauzin, P. Traktman, and A. J. Robinson. 1995. Identification and characterization of the orf virus type I topoisomerase. Virology 206:203-215.
7. Kornberg, A., and T. Baker. 1991. DNA replication. W. H. Freeman and Company, New York, N.Y.
8. Leirmo, S., C. Harrison, D. S. Cayley, R. R. Burgess, and M. T. Record. 1987. Replacement of potassium chloride by potassium glutamate dramatically enhances protein-DNA interactions in vitro. Biochemistry 26:2095-2101.
9. Lynn, R. M., M.-A. Bjornsti, P. R. Caron, and J. C. Wang. 1989. Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomerase I. Proc. Natl. Acad. Sci. USA 86:3559-3563.
10. Massung, R. F., J. J. Esposito, L. Lui, J. Qi, T. R. Utterback, J. C. Knight, L. Aubin, T. E. Yuran, J. M. Parsons, V. N. Loparev, N. A. Selivanov, K. F. Cavallaro, A. R. Kerlavage, B. W. J. Mahy, and J. C. Venter. 1993. Potential virulence determinants in terminal regions of variola smallpox virus genome. Nature 366:748-751.
11. Morham, S. G., and S. Shuman. 1992. Covalent and noncovalent DNA binding by mutants of vaccinia DNA topoisomerase I. J. Biol. Chem. 267: 15984-15992.
12. Petersen, B. O., R. L. Hall, R. W. Moyer, and S. Shuman. 1997. Characterization of a DNA topoisomerase encoded by Amsacta moorei entomopox-virus. Virology 230:197-206.
13. Petersen, B. O., and S. Shuman. 1997. Histidine 265 is important for covalent catalysis by vaccinia topoisomerase and is conserved in all eukaryotic type I enzymes. J. Biol. Chem. 272:3891-3896.
14. Petersen, C. S., and J. Gerstoft. 1992. Molluscum contagiosum in HIV-infected patients. Dermatology 184:19-21.
15. Porter, C. D., N. W. Blake, J. J. Cream, and L. C. Archard. 1992. Molluscum contagiosum virus, p. 233-257. In D. A. Wright and L. Archer (ed.), Molecular and cell biology of sexually transmitted diseases. Chapman and Hall, London, England.
16. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Press, Cold Spring Harbor, N.Y.
17. Schwartz, J. J., and P. L. Myskowski. 1992. Molluscum contagiosum in patients with human immunodeficiency virus infection. J. Am. Acad. Dermatol. 27:583-588.
18. Sekiguchi, J., and S. Schuman. 1997. Novobiocin inhibits vaccinia virus replication by blocking virus assembly. Virology 235:129-137.
19. Sekiguchi, J., and S. Shuman. 1994. Stimulation of vaccinia topoisomerase I by nucleoside triphosphates. J. Biol. Chem. 269:29760-29764.
20. Sekiguchi, J., and S. Shuman. 1994. Vaccinia topoisomerase binds circumferentially to DNA. J. Biol. Chem. 269:31731-31734.
21. Sekiguchi, J., and S. Shuman. 1996. Identification of contacts between topoisomerase I and its target DNA by site-specific photocrosslinking. EMBO J. 15:3448-3457.
22. Sekiguchi, J., J. T. Stivers, A. S. Mildvan, and S. Shuman. 1996. Mechanism of inhibition of vaccinia DNA topoisomerase by novobiocin and coumermycin. J. Biol. Chem. 271:2313-2322.
23. Senkevich, T. G., J. J. Bugert, J. R. Sisler, E. V. Koonin, C. Darai, and B. Moss. 1996. Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes. Science 273:813-816.
24. Senkevich, T. G., E. V. Koonin, J. J. Bugert, G. Darai, and B. Moss. 1997. The genome of molluscum contagiosum virus: analysis and comparison with other poxviruses. Virology 233:19-42.
25. Sharma, A., R. Hanai, and A. Mondragon. 1994. Crystal structure of the amino-terminal fragment of vaccinia virus DNA topoisomerase I at 1.6 Å resolution. Structure 2:767-777.
26. Sherman, P. A., and J. A. Fyfe. 1990. Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity. Proc. Natl. Acad. Sci. USA 87:5119-5123.
27. Shuman, S. 1991. Site-specific DNA cleavage by vaccinia virus DNA topoisomerase I. J. Biol. Chem. 266:1796-1803.
28. Shuman, S., M. Golder, and B. Moss. 1988. Characterization of vaccinia virus DNA topoisomerase I expressed in Escherichia coli. J. Biol. Chem. 263:16401-16407.
29. Shuman, S., M. Golder, and B. Moss. 1989. Insertional mutagenesis of the vaccinia virus gene encoding a type I DNA topoisomerase: evidence that the gene is essential for virus growth. Virology 170:302-306.
30. Shuman, S., and J. Prescott. 1990. Specific DNA cleavage and binding by vaccinia virus DNA topoisomerase I. J. Biol. Chem. 265:17826-17836.
31. Wang, J. C. 1996. DNA topoisomerases. Annu. Rev. Biochem. 65:635-692.